Pre-incubation of IBD LPMC with CH223191, a compound inhibiting interaction of Ahr with its ligands, completely abrogated the effect of NPD-0414-2 or NPD-0414-24 on IL-22 and IFN-γ expression. Here, AHR is linked to inflammatory bowel disease.